Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura
Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura
Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura
Submitted by
admin
on December 20, 2009 - 10:54am
Source:
Pipeline Review
News Tags:
Revolade
GSK
Headline:
Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura
Do Not Allow Advertisers to Use My Personal information
